These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18803535)

  • 1. How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000.
    Chen L; Rogers SL; Colagiuri S; Cadilhac DA; Mathew TH; Boyden AN; Peeters A; Magliano DJ; Shaw JE; Zimmet PZ; Tonkin AM;
    Med J Aust; 2008 Sep; 189(6):319-22. PubMed ID: 18803535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia.
    Banks E; Crouch SR; Korda RJ; Stavreski B; Page K; Thurber KA; Grenfell R
    Med J Aust; 2016 May; 204(8):320. PubMed ID: 27125809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease.
    Schilling C; Mortimer D; Dalziel K; Heeley E; Chalmers J; Clarke P
    Pharmacoeconomics; 2016 Feb; 34(2):195-205. PubMed ID: 26578402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark.
    Graversen L; Christensen B; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Scand J Prim Health Care; 2010 Mar; 28(1):47-54. PubMed ID: 19929180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines?
    Forge BH; Briganti EM
    Med J Aust; 2001 Nov; 175(9):471-5. PubMed ID: 11758075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute cardiovascular disease risk and lipid-lowering therapy among Aboriginal and Torres Strait Islander Australians.
    Calabria B; Korda RJ; Lovett RW; Fernando P; Martin T; Malamoo L; Welsh J; Banks E
    Med J Aust; 2018 Jun; 209(1):35-41. PubMed ID: 29929455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under-use of appropriate blood pressure-lowering and lipid-lowering therapy in the Busselton baby boomer population.
    Yiu W; Knuiman M; Wallace H; Hung J
    Aust J Gen Pract; 2019 Dec; 48(12):883-889. PubMed ID: 31774993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia.
    Luke JN; Brown A; O'Neal DN; O'Dea K; Jenkins AJ; Kelaher M; Best JD; Rowley KG
    Med J Aust; 2009 May; 190(10):552-6. PubMed ID: 19450200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle Mass and Body Fat in Relation to Cardiovascular Risk Estimation and Lipid-Lowering Eligibility.
    Lee K
    J Clin Densitom; 2017; 20(2):247-255. PubMed ID: 27939251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
    Chen L; Peeters A; Magliano DJ; Shaw JE; Welborn TA; Wolfe R; Zimmet PZ; Tonkin AM
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):740-5. PubMed ID: 18043293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2023 Australian guideline for assessing and managing cardiovascular disease risk.
    Nelson MR; Banks E; Brown A; Chow CK; Peiris DP; Stocks NP; Davies Ao R; Raffoul N; Kalman L; Bradburn E; Jennings G
    Med J Aust; 2024 May; 220(9):482-490. PubMed ID: 38623719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
    Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
    Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.
    Janus ED; Tideman PA; Dunbar JA; Kilkkinen A; Bunker SJ; Philpot B; Tirimacco R; Mc Namara K; Heistaro S; Laatikainen T
    Med J Aust; 2010 Feb; 192(3):127-32. PubMed ID: 20121678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaps in cardiovascular disease risk management in Australian general practice.
    Webster RJ; Heeley EL; Peiris DP; Bayram C; Cass A; Patel AA
    Med J Aust; 2009 Sep; 191(6):324-9. PubMed ID: 19769555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of cardiovascular disease: new guidelines, technologies and therapies.
    Nelson MR; Doust JA
    Med J Aust; 2013 Jun; 198(11):606-10. PubMed ID: 23919708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol-lowering therapy and the Australian Pharmaceutical Benefits Scheme: a population study.
    Adams RJ; Appleton S; Wilson DH; Taylor AW; Chittleborough C; Gill T; Ruffin RE
    Aust Health Rev; 2009 May; 33(2):325-33. PubMed ID: 19563324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare.
    Hyun KK; Redfern J; Patel A; Peiris D; Brieger D; Sullivan D; Harris M; Usherwood T; MacMahon S; Lyford M; Woodward M
    Heart; 2017 Apr; 103(7):492-498. PubMed ID: 28249996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.